Immunogenicity of High-Dose Egg-Based, Recombinant, and Cell Culture-Based Influenza Vaccines Compared With Standard-Dose Egg-Based Influenza Vaccine Among Health Care Personnel Aged 18-65 Years in 2019-2020.
Open Forum Infect Dis
; 10(6): ofad223, 2023 Jun.
Article
in En
| MEDLINE
| ID: mdl-37305842
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Clinical_trials
Language:
En
Journal:
Open Forum Infect Dis
Year:
2023
Document type:
Article
Affiliation country: